Navina, a NYC-based company which specializes in AI-powered clinical intelligence, raised $55M in Series C funding.
The round was led by Growth Equity at Goldman Sachs Alternatives, with participation from existing investors, including Vertex Ventures Israel, Grove Ventures and ALIVE, bringing the total funding to $100M.
The company intends to use the funds to accelerate its expansion across the U.S. healthcare market, enhance its proprietary AI technology, and further drive improvements in patient outcomes by bringing proactive clinical intelligence to every outpatient interaction.
Co-founded by Ronen Lavi and Shay Perera, Navina is an AI copilot that brings clinical intelligence to clinicians and care teams, improving care and value-based outcomes. Its AI turns fragmented patient data into a concise patient profile with actionable insights at every clinical touchpoint to reduce missed diagnoses, enhance quality metrics and risk adjustment accuracy, and alleviate the administrative burden, allowing providers to focus on their patients.
Navina’s AI copilot is used by Privia Health, agilon health, and Millennium Physician Group, among others.
FinSMEs
25/03/2025